IMRN
Price
$1.86
Change
+$0.03 (+1.64%)
Updated
Sep 3 closing price
Capitalization
10.37M
PHIO
Price
$2.08
Change
-$0.04 (-1.89%)
Updated
Sep 3 closing price
Capitalization
11.91M
Interact to see
Advertisement

IMRN vs PHIO

Header iconIMRN vs PHIO Comparison
Open Charts IMRN vs PHIOBanner chart's image
Immuron
Price$1.86
Change+$0.03 (+1.64%)
Volume$32.44K
Capitalization10.37M
Phio Pharmaceuticals
Price$2.08
Change-$0.04 (-1.89%)
Volume$145.71K
Capitalization11.91M
IMRN vs PHIO Comparison Chart in %
Loading...
IMRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMRN vs. PHIO commentary
Sep 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMRN is a StrongBuy and PHIO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 04, 2025
Stock price -- (IMRN: $1.83 vs. PHIO: $2.12)
Brand notoriety: IMRN and PHIO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMRN: 13% vs. PHIO: 35%
Market capitalization -- IMRN: $10.37M vs. PHIO: $11.91M
IMRN [@Biotechnology] is valued at $10.37M. PHIO’s [@Biotechnology] market capitalization is $11.91M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.69B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMRN’s FA Score shows that 1 FA rating(s) are green whilePHIO’s FA Score has 0 green FA rating(s).

  • IMRN’s FA Score: 1 green, 4 red.
  • PHIO’s FA Score: 0 green, 5 red.
According to our system of comparison, IMRN is a better buy in the long-term than PHIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMRN’s TA Score shows that 4 TA indicator(s) are bullish while PHIO’s TA Score has 4 bullish TA indicator(s).

  • IMRN’s TA Score: 4 bullish, 5 bearish.
  • PHIO’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, IMRN is a better buy in the short-term than PHIO.

Price Growth

IMRN (@Biotechnology) experienced а +4.29% price change this week, while PHIO (@Biotechnology) price change was +3.92% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.32%. For the same industry, the average monthly price growth was +16.10%, and the average quarterly price growth was +32.67%.

Industries' Descriptions

@Biotechnology (+0.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PHIO($11.9M) has a higher market cap than IMRN($10.4M). PHIO YTD gains are higher at: 17.778 vs. IMRN (7.353). IMRN (-7.35M) and PHIO (-7.45M) have comparable annual earnings (EBITDA) . PHIO has more cash in the bank: 10.8M vs. IMRN (7.74M). IMRN has higher revenues than PHIO: IMRN (6.54M) vs PHIO (0).
IMRNPHIOIMRN / PHIO
Capitalization10.4M11.9M87%
EBITDA-7.35M-7.45M99%
Gain YTD7.35317.77841%
P/E RatioN/A0.01-
Revenue6.54M0-
Total Cash7.74M10.8M72%
Total DebtN/A0-
FUNDAMENTALS RATINGS
IMRN vs PHIO: Fundamental Ratings
IMRN
PHIO
OUTLOOK RATING
1..100
562
VALUATION
overvalued / fair valued / undervalued
1..100
21
Undervalued
55
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9799
PRICE GROWTH RATING
1..100
5862
P/E GROWTH RATING
1..100
10062
SEASONALITY SCORE
1..100
8540

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IMRN's Valuation (21) in the Biotechnology industry is somewhat better than the same rating for PHIO (55). This means that IMRN’s stock grew somewhat faster than PHIO’s over the last 12 months.

IMRN's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as PHIO (100). This means that IMRN’s stock grew similarly to PHIO’s over the last 12 months.

IMRN's SMR Rating (97) in the Biotechnology industry is in the same range as PHIO (99). This means that IMRN’s stock grew similarly to PHIO’s over the last 12 months.

IMRN's Price Growth Rating (58) in the Biotechnology industry is in the same range as PHIO (62). This means that IMRN’s stock grew similarly to PHIO’s over the last 12 months.

PHIO's P/E Growth Rating (62) in the Biotechnology industry is somewhat better than the same rating for IMRN (100). This means that PHIO’s stock grew somewhat faster than IMRN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IMRNPHIO
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
80%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 6 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
67%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
69%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 6 days ago
74%
Bullish Trend 13 days ago
83%
Declines
ODDS (%)
Bearish Trend 15 days ago
89%
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
85%
Aroon
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
IMRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MPB30.11-0.03
-0.10%
Mid Penn Bancorp
EBMT17.37-0.16
-0.91%
Eagle Bancorp Montana
WSFS57.48-0.81
-1.39%
WSFS Financial Corp
CBOE231.88-4.07
-1.72%
Cboe Global Markets
GXAI1.65-0.07
-4.07%
Gaxosai

IMRN and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMRN has been closely correlated with RIGL. These tickers have moved in lockstep 82% of the time. This A.I.-generated data suggests there is a high statistical probability that if IMRN jumps, then RIGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMRN
1D Price
Change %
IMRN100%
-0.27%
RIGL - IMRN
82%
Closely correlated
-1.00%
CLNN - IMRN
80%
Closely correlated
+20.11%
AZTR - IMRN
72%
Closely correlated
-9.16%
PHIO - IMRN
72%
Closely correlated
+7.61%
ZLDPF - IMRN
52%
Loosely correlated
+1.00%
More

PHIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, PHIO has been closely correlated with RIGL. These tickers have moved in lockstep 84% of the time. This A.I.-generated data suggests there is a high statistical probability that if PHIO jumps, then RIGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PHIO
1D Price
Change %
PHIO100%
+7.61%
RIGL - PHIO
84%
Closely correlated
-1.00%
CLNN - PHIO
83%
Closely correlated
+20.11%
DARE - PHIO
81%
Closely correlated
+0.50%
IMRN - PHIO
71%
Closely correlated
-0.27%
TPST - PHIO
51%
Loosely correlated
+2.52%
More